Thomas S. Edgington
20Patents
15h-index
13Co-inventors
78Inventor score
Filing activity: Apr 30, 1976 → Nov 29, 2005
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5877289A | Tissue factor compositions and ligands for the specific coagulation of vasculature | Chemistry; Metallurgy | 160 | Expired |
| US6004555A | Methods for the specific coagulation of vasculature | Chemistry; Metallurgy | 118 | Expired |
| US6093399A | Methods and compositions for the specific coagulation of vasculature | Chemistry; Metallurgy | 88 | Expired |
| US6036955A | Kits and methods for the specific coagulation of vasculature | Chemistry; Metallurgy | 80 | Expired |
| US5110730A | Human tissue factor related DNA segments | Physics | 63 | Expired |
| US5223427A | Hybridomas producing monoclonal antibodies reactive with human tissue-factor glycoprotein heavy chain | Emerging Cross-Sectional Technologies | 52 | Expired |
| US4677057A | Diagnostic assay for the presence of apolipoproteins associated with plasma high density lipoproteins | Emerging Cross-Sectional Technologies | 50 | Expired |
| US5437864A | Method of inhibiting blood coagulation in extracorporeal circulation by inhibiting human tissue factor | Physics | 29 | Expired |
| US6001978A | Human tissue factor related DNA segments polypeptides and antibodies | Human Necessities | 25 | Expired |
| US5726147A | Human mutant tissue factor compositions useful as tissue factor antagonists | Human Necessities | 24 | Expired |
| US7691380B2 | Combined methods for tumor coagulation and tumor treatment | Chemistry; Metallurgy | 23 | Active |
| US5622931A | Human tissue factor related DNA segments, polypeptides and antibodies | Emerging Cross-Sectional Technologies | 19 | Expired |
| US4140753A | Diagnostic method and reagent | Emerging Cross-Sectional Technologies | 18 | Expired |
| US7608591B2 | Targeted delivery to legumain-expressing cells | Physics | 18 | Active |
| US6749853B1 | Combined methods and compositions for coagulation and tumor treatment | Chemistry; Metallurgy | 16 | Expired |
| US4785077A | Substantially pure cytotoxicity triggering factor | Emerging Cross-Sectional Technologies | 14 | Expired |
| US5994296A | Human mutant tissue factor compositions useful as tissue factor antagonists | Human Necessities | 13 | Expired |
| US4145336A | Carcinoembryonic antigen isomer | Emerging Cross-Sectional Technologies | 10 | Expired |
| US5473051A | Inhibition of Mac-1 receptor binding to fibrinogen using D.sub.30 homologs | Human Necessities | 7 | Expired |
| US7399743B2 | Targeted thrombosis | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.